Amron Arthur H: insider trades.
Amron Arthur H reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Amron Arthur H
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Nephros Inc (NEPH) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Nephros Inc | J | 2,836 | $0 | 2,836 | Form 4 |
| 2026-09-14 | Nephros Inc | J | 17,749 | $0 | 158,623 | Form 4 |
| 2026-09-14 | Nephros Inc | J | 22,710 | $3.95 | 25,546 | Form 4 |
| 2026-08-12 | Nephros Inc | A | 2,418 | $0 | 140,874 | Form 4 |
Questions
What stock did Amron Arthur H buy or sell?
Amron Arthur H reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Amron Arthur H the same person as other filers with this name?
This page covers SEC CIK 1179697 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/amron-arthur-h-1179697.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.